Falsely Lowered FT4 and Raised TSH Concentrations in a Patient with Hyperthyroidism and Human Anti-Mouse Monoclonal Antibodies

Kahn BB Weintraub BD Csako G Zweig MH . Factitious elevation of thyrotropin in a new ultrasensitive assay: Implications for the use of monoclonal antibodies in “sandwich” immunoassay. J Clin Endocrinol Metab 1988; 66: 625–33.

Bock JL Furgiuele J Wenz B. False positive immunometric assays caused by anti-immunoglobulin antibodies: A case report. Clin Chim Acta 1985; 147: 241–6.

Fiad TM Duffy J McKenna TJ . Multiple spuriously abnormal thyroid function indices due to heterophilic antibodies. Clin Endocrinol 1994; 41: 391–5.

Sakata S Nakamura S Miura K. Autoantibodies against thyroid hormones or iodothyronine. Implications in diagnosis, thyroid function, treatment and pathogenesis. Ann Intern Med 1985; 103: 579–89.

Weber TH Kapyaho I Tanner P. Endogenous interference in immunoassays in clinical chemistry. A review. Scand J Clin Lab Invest 1990; 50 (suppl 201): 77–82.

Ekins R. Validity of analog free thyroxin immunoassays. Clin Chem 1987; 33: 2137–52.

Thompson RJ Jackson AP Langlois N. Circulating antibodies to mouse monoclonal immunoglobulins in normal subjects: Incidence, species specificity, and effects on a two-site assay for creatine kinase-MB isoenzyme. Clin Chem 1986; 32: 476–81.

Reinsberg J. Different efficacy on various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay. Clin Biochem 1996; 29: 145–8.

Howanitz PJ Howanitz JH Lamberson HV Ennis KM . Incidence and mechanisms of spurious increases in serum thyrotropin. Clin Chem 1982; 28: 427–31.